| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$70.00
Est. +73%
|
$40.55 | $78.54 |
Target Met
|
$101.00
+149.1%
|
| Oct 01, 2024 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$74.00
Est. +47%
|
$50.49 | $90.15 |
Target Met
|
$53.01
+5.0%
|
| Sep 11, 2024 |
Inozyme Pharma Inc
INZY
|
BUY |
$16.00
Est. +207%
|
$5.21 | $6.24 |
Miss
|
$4.00
-23.2%
|
| Sep 11, 2024 |
Krystal Biotech Inc
KRYS
|
BUY |
$220.00
Est. +19%
|
$185.00 | $207.84 |
Miss
|
$324.75
+75.5%
|
| Jun 24, 2024 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$80.00
Est. +217%
|
$25.22 | $28.18 |
Miss
|
$14.92
-40.8%
|
| May 31, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$127.00
Est. +229%
|
$38.65 | $60.37 |
Miss
|
$25.38
-34.3%
|
| May 13, 2024 |
Fulcrum Therapeutics Inc
FULC
|
BUY |
$22.00
Est. +194%
|
$7.48 | $10.13 |
Miss
|
$3.51
-53.1%
|
| Apr 16, 2024 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$48.00
Est. +100%
|
$24.01 | $54.23 |
Target Met
|
$101.00
+320.7%
|
| Apr 15, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$124.00
Est. +189%
|
$42.87 | $60.37 |
Miss
|
$25.38
-40.8%
|
| Apr 15, 2024 |
Krystal Biotech Inc
KRYS
|
BUY |
$204.00
Est. +20%
|
$169.75 | $219.34 |
Target Met
|
$324.75
+91.3%
|
| Sep 28, 2023 |
Editas Medicine Inc
EDIT
|
BUY |
$17.00
Est. +146%
|
$6.92 | $6.05 |
Miss
|
$2.46
-64.5%
|
| Jun 17, 2022 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$25.00
Est. +541%
|
$3.90 | - | - |
$89.70
+2200.0%
|